Page last updated: 2024-11-01

norfloxacin and Cancer of Lung

norfloxacin has been researched along with Cancer of Lung in 2 studies

Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.

Research Excerpts

ExcerptRelevanceReference
"The efficacy of the prophylactic administration of sulfamethoxazole/trimethoprim (ST) plus norfloxacin (NFLX) versus ST alone to prevent the development of bacterial infection during chemotherapy-induced leukopenia was compared in patients with lung cancer."5.08A randomized controlled trial of sulfamethoxazole/trimethoprim plus norfloxacin versus sulfamethoxazole/trimethoprim alone for the prophylaxis of bacteria infection during chemotherapy for lung cancer. ( Kunikane, H; Kunitoh, H; Nagatomo, A; Okamoto, H; Watanabe, K, 1998)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bykowska, A1
Komarnicka, UK1
Jeżowska-Bojczuk, M1
Kyzioł, A1
Nagatomo, A1
Watanabe, K1
Kunikane, H1
Okamoto, H1
Kunitoh, H1

Trials

1 trial available for norfloxacin and Cancer of Lung

ArticleYear
A randomized controlled trial of sulfamethoxazole/trimethoprim plus norfloxacin versus sulfamethoxazole/trimethoprim alone for the prophylaxis of bacteria infection during chemotherapy for lung cancer.
    Lung cancer (Amsterdam, Netherlands), 1998, Volume: 19, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Combin

1998

Other Studies

1 other study available for norfloxacin and Cancer of Lung

ArticleYear
Cu
    Journal of inorganic biochemistry, 2018, Volume: 181

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Apopt

2018